BIT
Click for more information
0.00% 2.5¢ biotron limited

Ann: BIT225 Reverses HIV-Induced Impairment of the Immune System, page-17

  1. Pixie
    7,425 Posts.
    lightbulb Created with Sketch. 125
    clock Created with Sketch.
    23/07/14
    20:54
    Post #: 13704917
    nice find..

    I like that last line:

    "Dr Miller said Biotron was now seeking a major pharmaceutical partner to help it take BIT225 to the next level of clinical testing, which were expensive and required large numbers of patients."

    Just imagine TH following with news of a partnering deal......we will go through the roof...

    this 24% spike will seem like a hiccup...
    BIT Price at posting: 13.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $22.55M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $23.83K 953.1K

Buyers (Bids)

No. Vol. Price($)
2 141000 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 36000 1
View Market Depth
Last trade - 15.15pm 22/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.